Photo of Srinivas Viswanathan from dana-farber.org
Aug 9, 2023, 19:51
How chrX alterations may drive sex differences in cancer – Srinivas Viswanathan
Happy to share our latest collaborative preprint with CZ Zhang lab. We studied Xp11 translocation renal cell carcinoma (tRCC) – a rare kidney cancer – as a window into understanding how chrX alterations may drive sex differences in cancer.
For the article: Click here
Source: Srinivas Viswanathan / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 25, 2024, 14:04
Dec 25, 2024, 13:55
Dec 25, 2024, 13:50
Dec 25, 2024, 13:45
Dec 25, 2024, 13:38
Dec 25, 2024, 13:24
Dec 25, 2024, 13:19
Dec 25, 2024, 12:40
Dec 25, 2024, 12:29